Yasuhiro Terasaki

Researcher Name Resolver ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 9

Top Topics

Liver Metastases

Epidermal Growth Factor Receptor

Fine Needle Aspiration

Top Venues

OncoTargets and therapy

Journal of cellular and molecular medicine

Cellular microbiology

This page only lists publications with an associated author ORCID identifier.

Publications

Hirokazu Iso, Akihiko Miyanaga, Naohiro Kadoma, Kaoruko Shinbu, Takehiro Tozuka, Akari Murata, Shunichi Nishima, Yozo Sato, Shinji Nakamichi, Masaru Matsumoto, Rintaro Noro, Yasuhiro Terasaki, Kaoru Kubota, Masahiro Seike
Remarkable Clinical Response of ALK -Rearranged/ TP53 -Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report. OncoTargets and therapy 16 (2023)
Hirokazu Iso, Akihiko Miyanaga, Naohiro Kadoma, Kaoruko Shinbu, Takehiro Tozuka, Akari Murata, Shunichi Nishima, Yozo Sato, Shinji Nakamichi, Masaru Matsumoto, Rintaro Noro, Yasuhiro Terasaki, Kaoru Kubota, Masahiro Seike
Remarkable Clinical Response of ALK -Rearranged/ TP53 -Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report. OncoTargets and therapy 16 (2023)
Hirokazu Iso, Akihiko Miyanaga, Naohiro Kadoma, Kaoruko Shinbu, Takehiro Tozuka, Akari Murata, Shunichi Nishima, Yozo Sato, Shinji Nakamichi, Masaru Matsumoto, Rintaro Noro, Yasuhiro Terasaki, Kaoru Kubota, Masahiro Seike
Remarkable Clinical Response of ALK -Rearranged/ TP53 -Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report. OncoTargets and therapy 16 (2023)
Hirokazu Iso, Akihiko Miyanaga, Naohiro Kadoma, Kaoruko Shinbu, Takehiro Tozuka, Akari Murata, Shunichi Nishima, Yozo Sato, Shinji Nakamichi, Masaru Matsumoto, Rintaro Noro, Yasuhiro Terasaki, Kaoru Kubota, Masahiro Seike
Remarkable Clinical Response of ALK -Rearranged/ TP53 -Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report. OncoTargets and therapy 16 (2023)
Atsumi Enomoto, Mika Terasaki, Yukihiro Murase, Yasuyuki Kitagawa, Akira Shimizu, Ryuji Ohashi, Yasuhiro Terasaki
Malignant granular cell tumors: Combining cytological and pathological findings for a definitive diagnosis. Diagnostic cytopathology 50 (8) (2022)
Anna Hayashi, Shinji Nakamichi, Yukako Nakayama, Atsuhiro Nagano, Erika Mikami, Natsuki Takano, Takehiro Tozuka, Masaru Matsumoto, Akihiko Miyanaga, Rintaro Noro, Yasuhiro Terasaki, Kaoru Kubota, Masahiro Seike, Akihiko Gemma
Successful Treatment with Short-Term Steroid Against Severe Hepatitis Confirmed by Liver Biopsy in a Patient with Advanced Squamous-Cell Lung Cancer Receiving a Combination of Pembrolizumab, Carboplatin, and Nab-Paclitaxel: A Case Report. OncoTargets and therapy 15 (2022)
Kinnosuke Yahiro, Kohei Ogura, Yasuhiro Terasaki, Mamoru Satoh, Satoru Miyagi, Mika Terasaki, Eiki Yamasaki, Joel Moss
Cholix toxin, an eukaryotic elongation factor 2 ADP-ribosyltransferase, interacts with Prohibitins and induces apoptosis with mitochondrial dysfunction in human hepatocytes. Cellular microbiology 21 (8) (2019)
Yasuhiro Terasaki, Mika Terasaki, Satoshi Kanazawa, Nariaki Kokuho, Hirokazu Urushiyama, Yusuke Kajimoto, Shinobu Kunugi, Motoyo Maruyama, Toshio Akimoto, Yoko Miura, Tsutomu Igarashi, Ikuroh Ohsawa, Akira Shimizu
Effect of H2 treatment in a mouse model of rheumatoid arthritis-associated interstitial lung disease. Journal of cellular and molecular medicine 23 (10) (2019)
Yasuhiro Terasaki, Soichiro Ikushima, Shoko Matsui, Akira Hebisawa, Yasunori Ichimura, Shinyu Izumi, Masuo Ujita, Machiko Arita, Keisuke Tomii, Yuko Komase, Isoko Owan, Tetsuji Kawamura, Yasuo Matsuzawa, Miho Murakami, Hiroshi Ishimoto, Hiroshi Kimura, Masashi Bando, Norihiro Nishimoto, Yoshinori Kawabata, Yuh Fukuda, Takashi Ogura, null null
Comparison of clinical and pathological features of lung lesions of systemic IgG4-related disease and idiopathic multicentric Castleman's disease. Histopathology 70 (7) (2017)